盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300143 盈康生命

已收盘 04-03 15:00:00

{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":12.18,"timestamp":1775199780000,"preClose":13.2,"halted":0,"volume":31037096,"delay":0,"changeRate":-0.0773,"floatShares":641000000,"shares":749000000,"eps":0.0289,"marketStatus":"已收盘","change":-1.02,"latestTime":"04-03 15:00:00","open":12.98,"high":12.99,"low":12.15,"amount":386000000,"amplitude":0.0636,"askPrice":12.18,"askSize":530,"bidPrice":12.17,"bidSize":164,"shortable":0,"etf":0,"ttmEps":0.0289,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.2,"symbolType":"stock","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":14.52,"lowLimit":11.88,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":749451604,"isCdr":false,"pbRate":3.94,"roa":"--","peRate":421.453287,"roe":"2.78%","epsLYR":0.09,"committee":-0.132117,"marketValue":9128000000,"turnoverRate":0.0484,"status":1,"floatMarketCap":7811000000},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2623357768","title":"股市必读：盈康生命(300143)股东户数2.5万户，较上期增加0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623357768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623357768?lang=zh_cn&edition=full","pubTime":"2026-03-30 02:50","pubTimestamp":1774810218,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，盈康生命报收于12.53元，上涨1.13%，换手率4.25%，成交量27.28万手，成交额3.4亿元。股本股东变化股东户数变动截至2026年2月27日公司股东户数为2.5万户，较2月13日增加93.0户，增幅0.37%。该项计提减少2025年度利润总额2,458.74万元，减少归属于上市公司所有者权益2,300.64万元。盈康生命科技股份有限公司2025年度募集资金存放与使用情况鉴证报告2020年募集资金截至2025年末余额16,429,586.76元；2022年募集资金专户余额为0.00元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828224","title":"盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828224","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622828224?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:49","pubTimestamp":1774608557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盈康生命(300143.SZ)发布2025年年度报告，该公司营业收入为18.86亿元，同比增长20.93%。归属于上市公司股东的净利润为6854.07万元，同比减少40.62%。归属于上市公司股东的扣除非经常性损益的净利润为1.07亿元，同比增长28.50%。基本每股收益为0.09元。此外，拟向全体股东每10股派发现金红利0.25元(含税)，送红股0股(含税)，以资本公积金向全体股东每10股转增3股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"盈康生命(300143.SZ)发布2025年度业绩，归母净利润6854.07万元，下降40.62%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620289132","title":"盈康生命：公司目前暂无相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2620289132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620289132?lang=zh_cn&edition=full","pubTime":"2026-03-18 12:42","pubTimestamp":1773808932,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，注意到公司在布局AI制药相关方面，也注意到公司在和泓博医药有AI制药AI大模型相关的合作，泓博医药可以说是国内AI制药第一股，现在市值这么低潜力这么巨大，公司为什么不直接控股或者收购呢盈康生命回复：尊敬的投资者，您好！经核实，公司目前暂无相关合作，敬请投资者注意投资风险。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800019067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618626737","title":"盈康生命：肿瘤全周期管理智能体","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618626737?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:51","pubTimestamp":1773060681,"startTime":"0","endTime":"0","summary":"盈康生命发布了肿瘤场景智能体规划。这是一款围绕肿瘤场景打造的、面向患者端的智能体，旨在让每个肿瘤患者拥有自己的私人医生，是盈康生命肿瘤战略承接的一款核心产品。同时，公司联合联影智能、蚂蚁健康、惠美科技等生态伙伴，共同启动了“AI肿瘤全周期管理生态平台”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900032611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617422715","title":"盈康生命：已建立脑机接口治疗帕金森全流程管理方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2617422715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617422715?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:52","pubTimestamp":1772715172,"startTime":"0","endTime":"0","summary":"在康复机器人业务线上，是否有开展或规划类似的脑控协同研发，以把握技术融合先机？公司已建立起覆盖术前筛查、术中实施到术后监控、康复的脑机接口治疗帕金森全流程管理方案，旗下运城医院完成20余例脑起搏器植入术，为帕金森患者提供创新治疗方案。另外，公司托管的上海永慈康复医院联合生态方傅利叶共同打造了国内领先的康复机器人物联港。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500037421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617542200","title":"盈康生命：加速将AI能力与数字化手段融入既定战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2617542200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617542200?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:52","pubTimestamp":1772715162,"startTime":"0","endTime":"0","summary":"随着公司向“AI赋能的主动健康生态平台”战略升级，公司在物理网络布局的基础上，正加速将AI能力与数字化手段融入既定战略，通过“肿瘤全周期管理智能体”等创新产品，推动线下医疗资源与线上服务能力的深度融合，实现从传统“物理网络”向“智能生态”的持续演进。公司将结合市场环境与战略节奏审慎推进相关工作，后续进展请以公司公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500037416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617856819","title":"股市必读：盈康生命（300143）3月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2617856819","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617856819?lang=zh_cn&edition=full","pubTime":"2026-03-05 02:16","pubTimestamp":1772648174,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，盈康生命报收于10.58元，下跌0.28%，换手率1.12%，成交量7.17万手，成交额7594.92万元。董秘最新回复投资者： 改个名吧，我以为生命一号，以为公司是卖饮料的，不是说有一款饮品叫生命1号的吗？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500001209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614333108","title":"盈康生命落地上海首家具备独立CRRT能力的护理院，重构医养结合价值链条","url":"https://stock-news.laohu8.com/highlight/detail?id=2614333108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614333108?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:48","pubTimestamp":1772182104,"startTime":"0","endTime":"0","summary":"“脑、心、肺、肾”四大老年高发脏器疾病的中西结合围脏器诊疗中心，就是盈康护理集团对高龄群体“多病共存、康复周期长、治疗需求复杂”核心痛点的精准回应。这一突破能让高龄危重患者在熟悉环境中就能获得与三甲医院同质化的生命支持治疗，大幅降低转运风险，同时也让盈康护理院成为上海市首家具备独立开展CRRT能力的护理院。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026022700027052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614707724","title":"盈康生命：截至2026年2月13日，公司股东总数为24,872户","url":"https://stock-news.laohu8.com/highlight/detail?id=2614707724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614707724?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:54","pubTimestamp":1772013255,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最近一期公司的股东人数是多少？盈康生命回复：尊敬的投资者，您好！截至2026年2月13日，公司股东总数为24,872户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500031121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608230068","title":"盈康生命：截至2026年1月30日，公司股东总数为24,659户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608230068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608230068?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:18","pubTimestamp":1770106697,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司最新（1月31日）的股东人数是多少？谢谢盈康生命回复：尊敬的投资者，您好！截至2026年1月30日，公司股东总数为24,659户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300026317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606312617","title":"股市必读：盈康生命（300143）1月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606312617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606312617?lang=zh_cn&edition=full","pubTime":"2026-01-28 01:41","pubTimestamp":1769535669,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，盈康生命报收于11.81元，下跌1.17%，换手率1.8%，成交量11.52万手，成交额1.35亿元。董秘最新回复投资者： 尊敬的董秘，您好！公开信息显示，公司已战略转型为AI健康解决方案服务商，并拥有“盈康大脑”及覆盖“院前-院中-院后”的AI智能体。后续如在该领域有达到信息披露标准的实质性进展，公司将严格按照规定履行披露义务。当日关注点来自交易信息汇总：1月27日主力资金净流出1515.81万元，显示主力资金持续离场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800001050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605124214","title":"盈康生命：截至2026年1月20日股东总数为25,816户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605124214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605124214?lang=zh_cn&edition=full","pubTime":"2026-01-21 11:34","pubTimestamp":1768966493,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！截止2026年1月20日，股东总人数有多少盈康生命回复：尊敬的投资者，您好！截至2026年1月20日，公司股东总数为25,816户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100015180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603968243","title":"1月16日盈康生命跌5.04%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603968243?lang=zh_cn&edition=full","pubTime":"2026-01-16 15:40","pubTimestamp":1768549212,"startTime":"0","endTime":"0","summary":"证券之星消息，1月16日盈康生命跌5.04%，收盘报12.25元，换手率4.67%，成交量29.95万手，成交额3.72亿元。重仓盈康生命的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.56亿元，最新净值3.043，较上一交易日下跌1.07%，近一年上涨48.73%。该公募基金现任基金经理为方伟。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600019491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603502156","title":"盈康生命(300143)1月9日股东户数2.62万户，较上期增加28.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603502156","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603502156?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:38","pubTimestamp":1768297110,"startTime":"0","endTime":"0","summary":"证券之星消息，近日盈康生命披露，截至2026年1月9日公司股东户数为2.62万户，较12月31日增加5860.0户，增幅为28.83%。在医疗服务行业个股中，盈康生命股东户数低于行业平均水平，截至1月9日，医疗服务行业平均股东户数为4.5万户。从股价来看，2025年12月31日至2026年1月9日，盈康生命区间涨幅为19.84%，在此期间股东户数增加5860.0户，增幅为28.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602946325","title":"1月12日盈康生命涨12.16%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602946325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602946325?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:45","pubTimestamp":1768203950,"startTime":"0","endTime":"0","summary":"证券之星消息，1月12日盈康生命涨12.16%创60日新高，收盘报13.28元，换手率9.39%，成交量60.24万手，成交额7.84亿元。重仓盈康生命的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.56亿元，最新净值2.773，较上一交易日上涨2.67%，近一年上涨36.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200015321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601356606","title":"1月8日盈康生命涨7.39%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356606?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:38","pubTimestamp":1767857938,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日盈康生命涨7.39%创60日新高，收盘报11.62元，换手率7.09%，成交量45.46万手，成交额5.17亿元。重仓盈康生命的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.56亿元，最新净值2.63，较上一交易日下跌1.02%，近一年上涨27.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601133174","title":"盈康生命：提升经营质量实现可持续发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2601133174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601133174?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:34","pubTimestamp":1767843287,"startTime":"0","endTime":"0","summary":"公司高度重视市值管理和投资者回报，将企业价值视为市值管理的核心，致力于提升经营质量，实现长期可持续发展，并持续深化既有市值管理举措：严格遵守法律法规，确保公司运作的规范性；集中资源和精力于核心业务，增强公司在行业内的竞争优势；坚持稳健的经营策略，注重风险控制与长期发展；依法依规运用资本市场的各种工具和策略，增强公司的市场活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800015064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601080962","title":"盈康生命（300143）披露2025年度持续督导培训情况，1月7日股价下跌3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601080962","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601080962?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:13","pubTimestamp":1767795196,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，盈康生命报收于10.82元，较前一交易日下跌3.91%，最新总市值为81.09亿元。该股当日开盘11.26元，最高11.26元，最低10.77元，成交额达2.76亿元，换手率为3.92%。近日，国泰海通证券股份有限公司发布了关于盈康生命科技股份有限公司2025年度持续督导培训情况的报告。公告显示，作为盈康生命2020年非公开发行股票、2022年向特定对象发行股票的持续督导机构，国泰海通证券于2025年12月30日以现场和线上相结合的方式开展了2025年度持续督导培训。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601842780","title":"盈康生命：已建立脑机接口治疗帕金森全流程管理方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601842780","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601842780?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:15","pubTimestamp":1767748517,"startTime":"0","endTime":"0","summary":"请问盈康生命在脑科学与脑机接口方面的规划，以及在脑机外科手术的技术储备有哪些？在临床实践方面，公司已建立起覆盖术前筛查、术中实施到术后监控、康复的脑机接口治疗帕金森全流程管理方案。公司旗下运城医院完成20余例脑起搏器植入术，为帕金森患者提供创新治疗方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700005582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601892062","title":"盈康生命：向科技公司战略升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601892062?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:53","pubTimestamp":1767703987,"startTime":"0","endTime":"0","summary":"请问盈康生命在2026年有什么新的战略部署？公司正从“医疗服务与医疗器械双轮驱动的综合性医疗集团”向“为用户提供健康场景解决方案的科技公司”进行战略升级。公司将继续以肿瘤等核心专科领域为基石，并积极拓展居家健康等新场景，在深化现有“双轮驱动”业务协同的基础上，构建以科技创新为底座的健康管理平台，系统化地推进服务模式升级与价值链延伸。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600040123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775498674741,"stockEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":0.1512},{"period":"3month","weight":0.2328},{"period":"6month","weight":0.0665},{"period":"1year","weight":0.1929},{"period":"ytd","weight":0.2328}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"28621人(较上一季度增加14.64%)","perCapita":"22405股","listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","registeredCapital":"74945万元","survey":"　　盈康生命科技股份有限公司的主营业务是提供以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司的主要产品是医疗设备及耗材产品。","listedPrice":36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}